FSD Pharma Inc. submitted a 6-K filing to the SEC on February 28, 2024, indicating compliance with securities regulations. The filing includes a signature from CFO Nathan Coyle.
AI Assistant
QUANTUM BIOPHARMA LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.